The National Institute of Neurological Disorders and Stroke has awarded two UTHSC researchers over $1.9 million to study the pathogenesis of white matter damage, a main contributing factor to dementia. Francesca-Fang Liao, PhD, and Fu-Ming Zhou, PhD, both professors in the Department of Pharmacology, Addiction Science, and Toxicology, are co-investigators on the project titled "Blood-brain-barrier […]
Home »
Vaccines go mobile to keep seniors from slipping through the cracks
A mobile "strike team" is bringing vaccines to some of Northern California’s most vulnerable residents along with a message: This is how you avoid dying from covid-19. So far, that message has been met with both nervous acceptance and outbursts of joy from a population that has been ravaged by the disease. One 68-year-old pastor, […]
US pharmacy vaccine drive begins as cases fall
The United States’ Covid vaccination drive entered a new phase Thursday as thousands of pharmacies were scheduling shots, but a wave of optimism brought about by falling cases could soon be tested by dangerous variants. President Joe Biden’s administration was shipping a million doses to some 6,500 drugstores and supermarket pharmacies nationwide, with several chains […]
NewYork-Presbyterian working on machine learning analytics to combat opioid crisis
NewYork-Presbyterian, a prominent academic health system, is working with machine learning vendor Splunk to develop new data analytics tools that prevent the potential diversion of controlled substances such as opioids. NewYork-Presbyterian approached Splunk to develop the controlled substance monitoring platform, while also enhancing patient privacy, because of the vendor’s products’ ability to synthesize Big Data […]
23andMe lands $300 million investment from GlaxoSmithKline
23andMe on Wednesday announced that GlaxoSmithKline has invested $300 million to gain exclusive access to the genetic testing startup’s DNA database. The deal comes as GlaxoSmithKline amid reports that GSK is weighing the possibility of a company breakup and investors contending that synergies between consumer markets and big pharma are inherently limited and that GSK’s […]